Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults

João Albuquerque1, Ana Margarida Medeiros2, Ana Catarina Alves2

  • 1Departamento de Biomedicina, Unidade de Bioquímica, Faculdade de Medicina, Universidade do Porto, 4200-319, Porto, Portugal; Centro de Estatística e Aplicações, Faculdade de Ciências, Universidade de Lisboa, 1749-016, Lisboa, Portugal; Grupo de Investigação Cardiovascular, Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis, Instituto Nacional de Saúde Doutor Ricardo Jorge, 1649-016, Lisboa, Portugal.

Atherosclerosis
|October 9, 2023
PubMed

Insights

Early diagnosis of familial hypercholesterolaemia (FH) reduces cardiovascular disease risk. A new logistic regression model, trained on multiple cohorts, accurately identifies FH cases across diverse populations, outperforming traditional criteria.

Area of Science:

  • Cardiovascular disease research
  • Medical diagnostics
  • Machine learning in healthcare

Background:

  • Early diagnosis of familial hypercholesterolaemia (FH) significantly reduces cardiovascular disease (CVD) risk.
  • Current screening methods often rely on single-cohort studies, limiting generalizability.
  • Logistic regression (LR) and machine learning show promise for FH screening.

Purpose of the Study:

  • To develop and validate a logistic regression (LR) based algorithm for familial hypercholesterolaemia (FH) screening.
  • To assess the algorithm's performance across multiple national cohorts and an external dataset.
  • To compare the LR model's efficacy against traditional clinical criteria.

Main Methods:

  • Developed a logistic regression (LR) algorithm using data from three national FH cohorts (Portugal, Brazil, Sweden).
  • Validated the LR model on independent samples from these cohorts and an external Italian dataset.
  • Assessed discriminatory ability using AUROC and AUPRC; compared performance with Dutch Lipid Clinic Network (DLCN) criteria.

Main Results:

  • The LR model demonstrated higher AUROC and AUPRC values on testing sets compared to the training set.
  • Significantly more correct classifications were achieved with the LR model versus DLCN criteria across Brazilian, Swedish, and Italian test sets.
  • Improved accuracy, G mean, and F1 score were observed for all testing sets using the LR model.

Conclusions:

  • The LR model exhibits superior classification ability compared to DLCN criteria, identifying similar numbers of FH cases with fewer false positives.
  • The model shows excellent generalization across diverse populations, indicating its potential as an effective FH screening tool.
  • This multi-cohort developed algorithm offers a robust approach for widespread FH screening.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
565
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Pedigree Analysis01:35

Pedigree Analysis

Overview
84.4K